Barhemsys Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Barhemsys General Information

Description

Provider of pharmaceutical treatments for postoperative care based in the healthcare market. The company develops antiemetic medications such as Barhemsys, which target dopamine receptors to address postoperative nausea and vomiting, offering options for patients who do not respond to other therapies.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Barhemsys Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Barhemsys‘s full profile, request access.

Request a free trial

Barhemsys Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Barhemsys‘s full profile, request access.

Request a free trial

Barhemsys FAQs

  • Where is Barhemsys headquartered?

    Barhemsys is headquartered in .

  • What industry is Barhemsys in?

    Barhemsys’s primary industry is Drug Discovery.

  • Is Barhemsys a private or public company?

    Barhemsys is a Private company.

  • What is Barhemsys’s current revenue?

    The current revenue for Barhemsys is .

  • Who are Barhemsys’s investors?

    Eagle Pharmaceuticals has invested in Barhemsys.

  • When was Barhemsys acquired?

    Barhemsys was acquired on 14-Jan-2026.

  • Who acquired Barhemsys?

    Barhemsys was acquired by LXO Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process